AWH Valuation

Aspira Women's Health Inc

Add to Watchlist

Advanced Chart

0.000

-0.082(-100.000%)1D

Overview
Forecast
Valuation
Earnings

AWH Relative Valuation

AWH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AWH is overvalued; if below, it's undervalued.

Historical Valuation

Aspira Women's Health Inc (AWH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.12 is considered Undervalued compared with the five-year average of -12.66. The fair price of Aspira Women's Health Inc (AWH) is between 0.12 to 0.34 according to relative valuation methord. Compared to the current price of 0.04 USD , Aspira Women's Health Inc is Undervalued By 67.83%.

Relative Value

Fair Zone

0.12-0.34

Current Price：0.04

67.83%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

-0.64

P/B

Median3y

-11.02

Median5y

3.26

-416.54

FCF Yield

Median3y

-99.41

Median5y

-62.56

Competitors Valuation Multiple

The average P/S ratio for AWH's competitors is 0.60, providing a benchmark for relative valuation. Aspira Women's Health Inc Corp (AWH) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 10.28%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

AWH.O

Aspira Women's Health Inc

Loss

Average P/S: 0.60

10.28%